Predictive Strategy Building
Flagship is the ideal partner when you need to strengthen the predictive ability of the biomarker with:
- Quantitative data to establish the efficacy correlation earlier in clinical development; to
- Identify or expand the selected patient population with precision cutpoints.
Flagship’s approach increases the likelihood of success by identifying responsive patients using tests which can:
- Elucidate complex combinations of cell types to identify a responsive phenotype.
- Establish non-obvious correlations based on contextual relationships of cells to identify a key biology.
Our integrated scientific and clinical operations form the largest tissue image analysis laboratory in the world.
Flagship refined our thinking for a potential patient selection and diagnostic test, and definitely accelerated clinical time lines.